As European markets navigate a complex landscape marked by the ECB’s recent interest rate hike and ongoing geopolitical tensions, investors are closely monitoring small-cap stocks for potential opportunities. With the pan-European STOXX Europe 600 Index showing gains and hopes rising for a peace agreement in the Middle East, understanding what makes a good stock—such as strong fundamentals and favorable insider activity—can be crucial in identifying promising investments in this dynamic environment.
Top 10 Undervalued Small Caps With Insider Buying In Europe
Name
PE
PS
Discount to Fair Value
Value Rating
CellaVision
24.6x
4.5x
36.36%
★★★★★★
Eurocell
10.5x
0.3x
46.69%
★★★★★☆
Nederman Holding
17.1x
0.8x
32.45%
★★★★★☆
NoHo Partners Oyj
15.8x
0.4x
39.86%
★★★★★☆
Bilia
17.1x
0.3x
42.43%
★★★★☆☆
everplay group
7.0x
2.2x
10.61%
★★★★☆☆
Young’s Brewery
18.3x
1.0x
18.22%
★★★☆☆☆
AB Dynamics
NA
2.3x
32.69%
★★★☆☆☆
CVS Group
52.3x
1.2x
26.68%
★★★☆☆☆
Scatec
282.4x
4.4x
-10.40%
★★★☆☆☆
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Value Rating: ★★★☆☆☆
Overview: Logistea specializes in the acquisition, development, and management of logistics and warehouse properties, with a market capitalization of approximately SEK 2.05 billion.
Operations: Logistea’s revenue streams have shown significant fluctuations, with a notable increase from SEK 317.52 million in mid-2015 to SEK 1.12 billion by mid-2026. The company’s cost of goods sold (COGS) and operating expenses have varied over time, impacting its profitability. Gross profit margin has demonstrated an upward trend, reaching as high as 90.21% by early 2026, indicating improved efficiency in managing production costs relative to revenue generation.
PE: 7.4x
Logistea, a smaller European property company, is making strategic moves to expand its logistics portfolio. Recently, they agreed to acquire a cold storage facility in Vantaa for SEK 142 million with an annual rental income of SEK 10.7 million over eight years. This acquisition aligns with their growth strategy despite financial challenges such as earnings forecasts indicating a decline of 15.2% annually over the next three years and reliance on higher-risk external borrowings for funding. However, insider confidence is evident through recent share purchases by management members in the past quarter, suggesting belief in long-term potential amidst current financial strains.
Story Continues
OM:LOGI B Ownership Breakdown as at Jun 2026
Simply Wall St Value Rating: ★★★★★★
Overview: Nolato is a Swedish company specializing in the development and production of polymer product systems for medical, automotive, and consumer electronics industries with a market cap of approximately SEK 9.6 billion.
Operations: The company generates revenue primarily from its Medical Solutions and Engineered Solutions segments, with Medical Solutions contributing SEK 5.32 billion and Engineered Solutions SEK 4.06 billion. Over the observed periods, the gross profit margin has shown varied trends, reaching as high as 18.28% in recent quarters. Operating expenses have consistently included costs related to sales and marketing, general administrative tasks, and non-operating activities which impact net income margins over time.
PE: 17.4x
Nolato, a European company with strong industrial roots, is experiencing changes in leadership as Anders Björklund takes over as CEO from Christer Wahlquist by July 17, 2026. Despite recent earnings showing a slight dip in sales to SEK 2.36 billion and net income to SEK 181 million for Q1 2026, the company is on track for an annual earnings growth of over 12%. The absence of insider buying activity suggests cautious optimism among executives about future prospects amidst these transitions.
OM:NOLA B Share price vs Value as at Jun 2026
Simply Wall St Value Rating: ★★★☆☆☆
Overview: RaySearch Laboratories specializes in developing software solutions for radiation therapy used in cancer treatment, with a market capitalization of approximately SEK 5.74 billion.
Operations: RaySearch Laboratories generates revenue primarily from healthcare software, with recent figures showing SEK 1.30 billion in revenue. The company has experienced variations in its gross profit margin, which was last recorded at 92.41%. Operating expenses are a significant component of costs, with sales and marketing being the largest expense category followed by R&D and general & administrative expenses.
PE: 33.7x
RaySearch Laboratories, a software provider in the oncology sector, is capturing attention with its innovative solutions like RayStation and RayCare, which streamline radiotherapy workflows. Despite a dip in Q1 2026 sales to SEK 290.3 million from SEK 331.2 million the previous year, insider confidence remains strong with recent share purchases indicating potential value perception by those closely involved with the company. Their participation in ESTRO 2026 showcases groundbreaking advancements such as online adaptive radiotherapy, enhancing clinical precision and efficiency. With ongoing collaborations and expansions into markets like France and China, they are poised for growth amidst evolving healthcare demands.
OM:RAY B Share price vs Value as at Jun 2026 Turning Ideas Into Actions
Access the full spectrum of 79 Undervalued European Small Caps With Insider Buying by clicking on this link.
Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St’s portfolio, where intuitive tools await to help optimize your investment outcomes.
Streamline your investment strategy with Simply Wall St’s app for free and benefit from extensive research on stocks across all corners of the world.
Seeking Other Investments?
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include OM:LOGI B OM:NOLA B and OM:RAY B.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com